Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024 10

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024 10

Factors predict low BMD in pediatric blood cancer survivors

Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 inCancer.Hadley M. Bloomhardt, M.D., from the Yale School of

Updated on: May 11,2024 8

Factors predict low BMD in pediatric blood cancer survivors

Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 inCancer.Hadley M. Bloomhardt, M.D., from the Yale School of

Updated on:May 11,2024 8

New imaging technology for diagnosing and treating bowel cancer patients

byUniversity of GlasgowRepresentative transverse PET images from each mouse model and tracer. Credit:Clinical Cancer Research(2024). DOI: 10.1158/1078-0432.CCR-23-1063Biopsies are cu

Updated on: March 30,2024 0

New imaging technology for diagnosing and treating bowel cancer patients

byUniversity of GlasgowRepresentative transverse PET images from each mouse model and tracer. Credit:Clinical Cancer Research(2024). DOI: 10.1158/1078-0432.CCR-23-1063Biopsies are cu

Updated on:March 30,2024 0

Team develops AI model to improve patient response to cancer therapy

byAustralian National UniversityDr. Danh-Tai Hoang. Credit: The Australian National University (ANU).A new artificial intelligence (AI) tool that can help physicians to select the most suitable

Updated on: July 05,2024 0

Team develops AI model to improve patient response to cancer therapy

byAustralian National UniversityDr. Danh-Tai Hoang. Credit: The Australian National University (ANU).A new artificial intelligence (AI) tool that can help physicians to select the most suitable

Updated on:July 05,2024 0

Researchers map intricacies of lung cancer in one of their own

by Krista Conger,Stanford University Medical CenterJames Spudich (left) made an unusual offer last fall to colleague Mark Krasnow: a sample of a lung tumor that was to be removed from Spudich th

Updated on: June 04,2024 5

Researchers map intricacies of lung cancer in one of their own

by Krista Conger,Stanford University Medical CenterJames Spudich (left) made an unusual offer last fall to colleague Mark Krasnow: a sample of a lung tumor that was to be removed from Spudich th

Updated on:June 04,2024 5

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on: April 06,2024 0

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on:April 06,2024 0

Researchers uncover new targets for breast cancers resistant to standard therapies

by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b

Updated on: June 22,2024 5

Researchers uncover new targets for breast cancers resistant to standard therapies

by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b

Updated on:June 22,2024 5

Study finds patient messages help predict medication adherence

by Paul Govern,Vanderbilt UniversityCredit: CC0 Public DomainAround two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, wi

Updated on: March 06,2024 20

Study finds patient messages help predict medication adherence

by Paul Govern,Vanderbilt UniversityCredit: CC0 Public DomainAround two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, wi

Updated on:March 06,2024 20

Scientist identifies gene responsible for spread of prostate cancer

by Caitlin Coyle,Rutgers UniversityAntonina Mitrofanova is a pioneer in the emerging field of biomedical informatics, fighting cancer with big data. Credit: Nick RomanenkoA Rutgers study has fou

Updated on: March 06,2024 10

Scientist identifies gene responsible for spread of prostate cancer

by Caitlin Coyle,Rutgers UniversityAntonina Mitrofanova is a pioneer in the emerging field of biomedical informatics, fighting cancer with big data. Credit: Nick RomanenkoA Rutgers study has fou

Updated on:March 06,2024 10

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on: March 30,2024 0

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on:March 30,2024 0

Researchers map activity of inherited gene variants linked to prostate cancer

by UT Southwestern Medical CenterCredit: Pixabay/CC0 Public DomainUT Southwestern researchers have identified the molecular function of 87 inherited genetic variants that affect the risk of prost

Updated on: January 30,2024 10

Researchers map activity of inherited gene variants linked to prostate cancer

by UT Southwestern Medical CenterCredit: Pixabay/CC0 Public DomainUT Southwestern researchers have identified the molecular function of 87 inherited genetic variants that affect the risk of prost

Updated on:January 30,2024 10

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Updated on: February 18,2024 16

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Updated on:February 18,2024 16